Clinical Trials Insight: 700043602

Trial Profile

Clinical Trials Insight: 700043602

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jan 2010

At a glance

  • Drugs CB 182804 (Primary)
  • Indications Gram-negative infections
  • Focus Adverse reactions
  • Sponsors Cubist Pharmaceuticals
  • Most Recent Events

    • 25 Jan 2010 Status changed from recruiting to active, no longer recruiting, according to a Cubist Pharmaceuticals media release.
    • 20 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top